Medtronic secures FDA and CE Mark approvals for LINQ II cardiac monitor
LINQ II is a small wireless ICM intended for patients with abnormal heart rhythms who experience infrequent symptoms…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jul 20
LINQ II is a small wireless ICM intended for patients with abnormal heart rhythms who experience infrequent symptoms…
08 Jul 20
Previously Hemovent closed a $5.2 million Series B round on the expectation of a regulatory approval of its…
07 Jul 20
The Gallant implantable cardioverter defibrillator family of devices feature bluetooth capability to enable connection between patients and doctors
07 Jul 20
New data on successful transplantations for high-risk profile donor hearts presented at the American Transplant Congress
03 Jul 20
inHEART is a spin-off from IHU Liryc and Inria, two worldwide leading centers respectively in cardiac electrophysiology and…
29 Jun 20
REDUCER-I is a multi-centre, international, three-arm prospective and retrospective observational clinical study of Neovasc Reducer to treat refractory…
26 Jun 20
The partnership will combine the latest innovations in technology for integrated cardiovascular solutions to deliver on the quadruple…
25 Jun 20
Epygon is an advanced mitral technology that will help treat both left ventricle disease and mitral regurgitation at…
24 Jun 20
Miracor Medical provides solutions for the treatment of severe cardiac diseases, aiming to improve short and long-term clinical…
23 Jun 20
Foldax is developing Tria valve technology in partnership with Caltech and Australia’s science agency CSIRO